Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
1
1
1
0
1
0
Gross Profit
-1
-1
-1
0
0
0
Selling, General & Admin
0
0
0
0
0
0
Research & Development
--
--
--
--
--
--
Operating Expenses
0
0
0
0
0
0
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
9
9
0
0
5
4
Income Tax Expense
0
0
0
0
0
--
Net Income
9
9
0
0
5
4
Net Income Growth
--
--
--
-100%
25%
-500%
Shares Outstanding (Diluted)
4.65
5.05
4.93
4.8
4.29
4.04
Shares Change (YoY)
2%
3%
3%
12%
6%
3%
EPS (Diluted)
1.97
1.81
0.1
0.05
1.21
1.18
EPS Growth
1,700%
1,567%
86%
-95%
3%
-374%
Free Cash Flow
0
0
0
-3
0
-2
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
0%
0%
0%
0%
0%
0%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
--
--
--
--
--
--
EBITDA Margin
--
--
--
--
--
--
D&A For EBITDA
--
--
--
--
--
--
EBIT
-1
-1
-1
0
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
--
Follow-Up Questions
What are Daxor Corp's key financial statements?
According to the latest financial statement (Form-10K), Daxor Corp has a total asset of $46, Net profit of $9
What are the key financial ratios for DXR?
Daxor Corp's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Daxor Corp's revenue broken down by segment or geography?
Daxor Corp largest revenue segment is Investment and Related Activities, at a revenue of -135,668 in the most earnings release.For geography, United States is the primary market for Daxor Corp, at a revenue of -135,668.
Is Daxor Corp profitable?
yes, according to the latest financial statements, Daxor Corp has a net profit of $9